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doi:10.1016/j.kjms.2010.10.002Abstract Rhabdomyosarcoma (RMS) is the most common soft tissue tumor of childhood;
about 80% of cases occur before the age of 21 with the remaining 20% evenly spread throughout
the remaining decades. A primary paratesticular site is considered to have a good prognosis in
comparison with other RMS sites. Histologically, any subtype of RMS, including alveolar,
pleomorphic, embryonal, and mixed type, may occur in the paratesticular region, but only
a relatively small number of cases are mixed and this variant has a poor prognosis. We report





Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Malignant soft tissue tumors account for most of the
malignancies that occur in the paratesticular region.
Rhabdomyosarcoma (RMS) is the most common soft tissueof Urology, Kaohsiung Medical U
tw (C.-H. Huang).
vier Taiwan LLC. All rights reservtumor of childhood, and is responsible for approximately
one-half of all soft tissue sarcomas in this age group [1].
About 80% of RMS occurs before the age of 21, with the
remaining 20% evenly spread throughout the remaining
decades [2]. Any body part can be affected by RMS, butniversity, Kaohsiung, Taiwan.
ed.
Figure 1. Gross appearance of left paratesticular rhabdomyosarcoma.
240 H.-Y. Lee et al.a primary paratesticular site is considered to have a good
prognosis in comparison with other RMS sites [3]. The
treatment of paratesticular RMS has evolved considerably
over the past several decades. Cure rates have risen,
largely because of increasingly intensive multimodality
therapeutic protocols that have been developed by large
international cooperative groups, such as the Intergroup
Rhabdomyosarcoma Study Group [4]. Histologically, any
subtype of RMS may occur in the paratesticular region,
although the most common are embryonal, alveolar, and
pleomorphic. Only a relatively small number of cases of
mixed-type RMS have been reported, and they have had
a generally poor prognosis. This report documents a case of
paratesticular RMS, mixed embryonal and alveolar type,
that occurred in a 16-year-old boy.
Case presentation
A 16-year-old boy, with no history of systemic disease,
presented to our urologist with a palpable mass of the left
testis in July, 2007. There were no other specific complaints
such as scrotal pain, fever, chilliness, voiding pain, hema-
turia, burning sensation, or lower urinary tract symptoms.
Physical examination revealed a left scrotal mass with
hardness and mild tenderness (Fig. 1). Serum levels of
a-fetoprotein and b-human chorionic gonadotrophin wereFigure 2. Pelvic computed tomography showed left extratestic
external compression of the left testis.within norms. Scrotal ultrasonography of the left testicular
region showed left extratesticular masses with compression
of the left testis. Computed tomography of the abdomen
and pelvis was in line with a left, extratesticular, soft tissue
mass in the scrotum with external compression of the left
testis and central necrosis, although without definite
lymphadenopathy or metastasis (Fig. 2). He had no known
family history of genitourinary tract disease. He received
left intrascrotal tumor excision and left orchiopexy, with
preserved testis and spermatic cord, on December 6, 2007.
Microscopic examination found alternating areas of
dense compact cellularity and loose myxoid tissue. Most
areas revealed spindle cells exhibiting blunted central
nuclei and tapered end nuclei with cytoplasmic cross stri-
ations arranged in densely arrayed whorls or fascicular
patterns. Furthermore, primitive ovoid cells with scant
cytoplasm and differentiated rhabdomyoblasts with
eccentric nuclei and dense eosinophilic cytoplasm were
also noted. Immunohistochemistry for these neoplasms was
CK(), myogenin(þ), desmin(þ), S-100 (focal positive),
alpha-smooth muscle actin (focal positive), and CD34().
The final diagnosis was mixed embryonal and alveolar RMS
and the margin of soft tissue was negative for malignancy
(Fig. 3).
Chromosome analysis was normal and bone marrow
examination revealed normal cellularity with adequateular soft tissue mass in the scrotum with central necrosis and
Figure 3. (A) Classic rhambdomyoblasts with abundant eosinophilic cytoplasm and eccentric nuclei; cross-striation was seen in
some areas (H&E, 100). (B) Embryonal component with small round or spindle cells (H&E, 200). (C) Alveolar component: nests of
small size tumor cells separated by fibrous stroma (H&E, 200).
Mixed-type paratesticular rhabdomyosarcoma 241megakaryocytes. After surgery, he received chemotherapy
including vincristine, dactinomycin, and cyclophospha-
mide, and underwent follow-up abdominal computed
tomography. There have been no further signs of metastasis
or recurrence.
Discussion
RMS is the most common soft tissue sarcoma of childhood.
Paratesticular RMS often presents as a painless palpable
scrotum mass and comprises about 7% of all RMSs [5]. In
addition to paratesticular RMS, the sarcoma may arise from
other sites in the genitourinary system. The differences
between paratesticular RMS and RMS in other sites include
tumor position and subtype. Paratesticular RMS is easier to
diagnose and treat early, because of the superficial and
easier-to-access nature of the site [6]. Subtypes include
alveolar, pleomorphic, embryonal, and mixed type [7].
More than 90% of paratesticular RMSs have embryonal
histology, although this subtype has a better prognosis than
alveolar, which more easily spreads to distant sites or
lymph nodes. To our knowledge, mixed embryonal and
alveolar RMS is rare. To evaluate the prognosis for RMS,
tumor stage is important. Investigation includes physical
examination, chest X-ray, abdominal and chest computed
tomography, bone scan, and bone marrow analysis [8]. We
used the tumor-nodes-metastases system for staging and
our patient presented T1aN0M0. It showed better prognosis
without metastases.
Treatment of RMS includes surgery, chemotherapy, and
radiotherapy. Initially, the most effective treatment is
tumor excision and radical orchiectomy with high ligation of
the cord. Chemotherapy after surgery can improve the
prognosis and prevent metastases. Paratesticular RMS is
sensitive to a chemotherapy regimen of vincristine, actino-
mycin D, and cyclophosphamide. A trans-scrotal approach
will increase the risk of recurrence because of scrotal
contamination, so primary reexcision, which consists of
hemiscrotectomy with a high resection of the spermatic
cord, is recommended [9]. Our patient would not acceptorchiectomy and wanted to preserve the testis and cord, so
we performed adjuvant chemotherapy to avoid the possi-
bility of metastasis. After more than 2 years of follow-up, no
signs of this or recurrence have been noted. Even with a high
incidence of retroperitoneal lymph node metastasis, lymph
node dissection is controversial, especially when no
evidence of lymph node involvement is noted on abdominal
computed tomography.
Because the patient had mixed embryonal and alveolar
RMS, regular follow-up has been necessary. In any case,
early diagnosis and treatment are key to better survival
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